Home  >> Transactions>> Abbott has sold certain pharmaceutical assets to Inventiva

Abbott has sold certain pharmaceutical assets to Inventiva

Abbott Laboratories (NYSE: ABT) has sold the assets of Fournier R&D laboratories, located in Daix, France, to Inventiva, a company created as part of a management buyout. The assets include 12 000 m² of laboratories and equipment and a 230,000 molecule library, and will address four therapeutic targets: Parkinson’s disease, oncology, autoimmune diseases and fibrosis. In addition Abbott has signed a five-year partnership with Inventiva that will finance a large part of the operating costs. EC Mergers & Acquisitions acted as exclusive advisor to Abbott on this transaction.

Others

Dickson Data has been sold to May River Capital      Learn More >>
SPX has acquired Schonstedt Instrument Company      Learn More >>
Quantachrome Instruments has been sold to Anton Paar      Learn More >>
PIP Global has partnered with Audax Private Equity      Learn More >>
Harvard Bioscience has acquired Data Sciences International      Learn More >>
Horizon Technology has been sold to Biotage      Learn More >>
Norsk Elektro Optikk has sold NEO Monitors to Nederman      Learn More >>
AppliTek has been acquired by Hach / Danaher      Learn More >>
4titude is sold to Brooks Automation      Learn More >>
FFL Partners has acquired Bacharach      Learn More >>
Aliaxis has sold SED to Samson      Learn More >>
Spectris has sold Microscan to Omron      Learn More >>